Carole Deyts

Carole Deyts has extensive work experience in the scientific field. Carole began their career in 2002 as an Engineer at Oncodesign Biotechnology. In 2005, they became a Post Doctoral Scholar at the University Pierre and Marie Curie, CNRS. From 2008 to 2017, they worked at the University of Chicago as a Research Associate and Assistant Professor. During this time, they led research projects, developed innovative assays, and obtained funding for research. In 2017, they moved to the Gene Therapy Program as a Senior Research Investigator, Gene Therapy. In 2018, they joined Spark Therapeutics, Inc., Roche Group as a CNS Senior Research Scientist. Most recently, in 2020, they became a Senior Scientist III at Vanqua Bio.

Carole Deyts obtained their Baccalaureate (A-levels) in Sciences from High School Victor Duruy, Mont de Marsan in 1995. Carole then went on to obtain two Master's degrees from the University of Bordeaux in Physiology from 1996-1999. Following this, Carole Deyts earned their Master's degree in Biology from the University Pierre and Marie Curie in 2000-2001. Finally, they obtained their Ph.D. in Cell and Molecular Biology from the University of Paris XI (Paris, France), Institut of Neurobiology, Gif sur Yvette in 2002-2005.